A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions

Cancer

Volumn 112, Issue 3, 2008, Pages 650-658

  Milano, Michael T ^a   Katz, Alan W ^a   Muhs, Ann G ^a   Philip, Abraham ^a   Buchholz, Daniel J ^b   Schell, Michael C ^a   Okunieff, Paul ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

Disease burden; Local control; Oligometastases; Stereotactic body radiation

Indexed keywords

ADRENAL METASTASIS; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; OLIGOMETASTATIC DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; STEREOTACTIC TREATMENT; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOSURGERY; TREATMENT OUTCOME;

EID: 38749149183     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23209     Document Type: Article

References (25)

1. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8-10.
2. Mehta N, Mauer AM, Hellman S, et al. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004;25:1677-1683.
3. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol. 1994;12:2229-2234.
4. Withers HR, Lee SP. Modeling growth kinetics and statistical distribution of oligometastases. Semin Radiat Oncol. 2006;16:111-119.
5. Hellman S, Weichselbaum RR. Importance of local control in an era of systemic therapy. Nat Clin Pract Oncol. 2005;2:60-61.
6. Tait CR, Waterworth A, Loncaster J, Horgan K, Dodwell D. The oligometastatic state in breast cancer: hypothesis or reality. Breast. 2005;14:87-93.
7. Aboulafia AJ, Levine AM, Schmidt D, Aboulafia D. Surgical therapy of bone metastases. Semin Oncol. 2007;34:206-214.
8. Kanner AA, Bokstein F, Blumenthal DT, Ram Z. Surgical therapies in brain metastasis. Semin Oncol. 2007;34:197-205.
9. Kuvshinoff B, Fong Y. Surgical therapy of liver metastases. Semin Oncol. 2007;34:177-185.
10. Sternberg DI, Sonett JR. Surgical therapy of lung metastases. Semin Oncol. 2007;34:186-196.
11. Carey-Sampson M, Katz A, Constine LS. Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge? Semin Radiat Oncol. 2006;16:67-76.
12. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007;25:947-952.
13. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol. 2006;16:77-84.
14. Benedict SH, Galvin J, Hinson W, et al.; SBRT Task Group 101 Members. AAPM report. Stereotactic body radiotherapy. Report of Task Group 101. Available at URL: http://www.aapm.org/org/structure/default.asp7committee_code=TG101. Accessed August 15, 2007.
15. Schell MC, Bova FJ, Larson DA, et al.; Task Group 42. AAPM report no. 54. Stereotactic body radiotherapy. Report of Task Group 42, 1995. Available at URL: http://www.aapm.org/pubs/reports/rpt_54.pdf. Accessed August 15, 2007.
16. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys. 2007;67:793-798.
17. Okunieff P, Petersen AL, Philip A, et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol. 2006;45:808-817.
18. Singh D, Yi WS, Brasacchio RA, et al. Is there a favorable subset of patients with prostate cancer who develop oligometastases? Int J Radiat Oncol Biol Phys. 2004;58:3-10.
19. O'Dell WG, Schell MC, Reynolds D, Okunieff R. Dose broadening due to target position variability during fractionated breath-held radiation therapy. Med Phys. 2002;29:1430-1437.
20. Biswas T, Sandhu AP, Singh DP, et al. Low-dose radiosurgery for benign intracranial lesions. Am J Clin Oncol. 2003;26:325-331.
21. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-216.
22. Chawla S, Okunieff P, Chen Y, Katz AW, Schell MC, Milano MT. Stereotactic body radiation therapy (SBRT) for the treatment of adrenal metastases. Presented at the First International Symposium on Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery, Lake Buena Vista, Fla, February 23-25, 2007.
23. Khan AJ, Mehta PS, Zusag TW, et al. Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). Radiother Oncol. 2006;81:163-167.
24. Weichselbaum RR, Salama JK, Mehta N, et al. Phase I dose escalation of hypofractionated radiation therapy for patients with oligometastasis. Presented at the 48th Annual Meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO), Philadelphia, Pa, November 5-9, 2006. Abstract 2564.
25. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for 4 or more intracranial metastases. Int J Radiat Oncol Biol Phys. 2006;64:898-903.